Authors: Zhan Hao、Wan Jia

Regarding the premium revenue, now China is the second biggest insurance market in this world, but regulators and insurance undertakings always feel cross due to the lack of insurance innovation, especially for the insurance product. More specifically, most of sold insurance products in China were transplanted from the foreign markets, and

Authors: Lan Li and Jiayue Zhang

China is looking to strengthen its export control mechanisms by introducing a new Export Control Law. The draft Export Control Law (“Draft Law”) was issued in 2017 for public comments.  In recent months, the “State Council’s 2019 Legislative Work Plan” has clearly included the “Export Control Law” in its

Authors: Ren Gulong、Zhang Jiaqi

On 23 October 2019, the State Administration of Foreign Exchange (“SAFE”) issued a Circular on Further Promoting Cross-border Trade and Investment Facilitation (关于进一步促进跨境贸易投资便利化的通知) (“Circular No. 28”) which introduced 12 measures to further facilitate cross-border trade and investment. Among them, there are three key reforms in respect of

Author: Zhan Hao、Wan Jia

Insurance subrogation is an important legal mechanism for the insurers to reduce their losses after the insurance indemnities are paid. However, there are different opinions about the application of reinsurers’ right of subrogation. Whether the subrogation can be directly exercised by the reinsurers against the liable third party? Should the reinsurance

For a few years, the topic of whether antitrust civil disputes could be arbitrable had been hotly debated in China. There were few precedents in connection with this issue for people to better understand what China’s judicial position is, and local courts presented discrepant attitudes toward this issue in the past. Nevertheless, the Supreme People’s

Concurrences in partnership with Fordham Competition Law Institute will hold the inaugural Antitrust in Life Sciences on Monday, 23 March, 2020 from 1:30 to 6:30 pm at Fordham Law School in New York.Confirmed keynote speakers are:

(1) FTC Commissioner Noah Joshua Phillips,

(2) Paul Csiszár, European Commission – DG COMP’s Head of Antitrust Unit for

Concurrences in partnership with GW Law will hold the 7th annual Bill Kovacic Antitrust Salon on Monday, Sep 9, 2019 from 1 to 6 pm at Marvin Center, GWU in Washington, DC.

The keynote speeches will be delivered by FTC Commissioner Rohit Chopra (opening), and DOJ AAG Makan Delrahim (closing).

There will be three panels:

by Yu Dan, Dong Xin

For foreign investors, who are eager for an admission ticket into the Chinese insurance market, obtaining an insurance intermediary license in China would be one of the considerable options.

A Chinese insurance agency company, as an investable target, undoubtedly has a great attraction to foreign investors. Comparing with insurance brokerage

It is often puzzling and difficult for foreign reinsurers to navigate through Chinese legal frameworks on reinsurance contracts, especially since there are relatively fewer regulations to offer guidance on reinsurance contracts compared to the extensive regulations on direct insurance.

Moreover, since the reinsurance business often involves small groups of close acquaintances, it is often the

                                                                                                                                      Yang Zhan
On May 31, 2019, the Ministry of Commerce of China (“MOFCOM”) announced that China will establish an “Unreliable Entity List” (“UEL”) targeting on foreign entities and individuals that fail to comply with the principles of market economy, deviate from the contractual spirit, or cut off supplies to Chinese companies for non-commercial purposes, as